Rheumatology Medical News about bisphosphonates;low serum vitamin D levels

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Are bisphosphonates effective and safe in patients with low serum vitamin D levels?
International Journal of Clinical Rheumatology, 05/07/09

Antoniucci DM et al. – Study concludes that physicians should continue to prescribe adequate supplies of vitamin D within the target of therapy; for example, above 50 nmol/l during therapy with bisphosphonates, since adequate vitamin D levels counteract elevated parathyroid hormone levels, reduce bone resorption and have a positive effect on neuromuscular performance and on the risk of falling and bone strength.

Methods

Aim was to investigate if vitamin D deficiency may blunt the increase in bone mineral density during treatment with bisphosphonates (etidronate)
Data was analyzed from 1000 randomly selected pts from alendronate Phase III Trials, FIT 1 and FIT 2
All pts were treated with alendronate
Pts who had a daily calcium intake of <1000 mg were supplied with 500 mg calcium and 250 IU cholecalciferol

Results

No difference in the change in BMD of the lumbar spine and hips pts with vit D deficiency, vit D insufficiency and sufficient vit D levels at baseline
At first sight, it seems reassuring that baseline vit D levels do not interfere with the treatment effect

Exclusive Author Commentary
lems, 06/03/09

I am happy with the paper, since it is dealing with a clinically relevant question: are the widely prescribed bisphosphonates effective and safe in patients with low serum vitamin D levels. I suppose it is attractive for clinicians to read about the consequences of prescribing a bisphosphonate in patients with a low vitamin D level.

<< Previous
Anti-TNF-induced lupus

Next >>
Enhanced reactivity to pain in patients with rheumatoid arthritis